Codiak BioSciences, Inc. Cash and Restricted Cash
Codiak BioSciences, Inc. had Cash and Restricted Cash of $55.93 million as of 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2022-11-03
- 2022-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $55.93M.
- 2022-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $45.95M.
- 2022-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $60.66M.
- 2021-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $81.11M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2022-09-30 | $55.93M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $45.95M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $60.66M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $81.11M 10-K · filed 2022-03-10 |
| 2021-09-30 | $102.75M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $117.85M 10-Q · filed 2022-08-04 |
| 2021-03-31 | $134.44M 10-Q · filed 2022-05-05 |
| 2020-12-31 | $93.08M 10-K · filed 2022-03-10 |
| 2020-09-30 | $52.51M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $55.48M 10-Q · filed 2021-08-05 |
| 2020-03-31 | $52.38M 10-Q · filed 2021-05-06 |
| 2019-12-31 | $14.85M 10-K · filed 2021-03-17 |
| 2019-09-30 | $36.60M 10-Q · filed 2020-11-19 |